NCT01157169View on ClinicalTrials.gov

Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Healthy
Interventions
DRUG

Buprenorphine

8 mg Sublingual Tablets

DRUG

Buprenorphine

8 mg Sublingual Tablets

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01157169 - Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter